112 related articles for article (PubMed ID: 33602480)
1. Delaying definitive resection in early stage (I/II) colon cancer appears safe up to 6 weeks.
Davidson JT; Abelson JS; Glasgow SC; Hunt SR; Mutch MG; Wise PE; Silviera ML; Smith RK
Am J Surg; 2021 Aug; 222(2):402-407. PubMed ID: 33602480
[TBL] [Abstract][Full Text] [Related]
2. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
Ejaz A; Casadaban L; Maker AV
J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
[TBL] [Abstract][Full Text] [Related]
3. Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer.
Turner MC; Farrow NE; Rhodin KE; Sun Z; Adam MA; Mantyh CR; Migaly J
J Am Coll Surg; 2018 Apr; 226(4):670-678. PubMed ID: 29378259
[TBL] [Abstract][Full Text] [Related]
4. How Soon Should Patients With Colon Cancer Undergo Definitive Resection?
Kucejko RJ; Holleran TJ; Stein DE; Poggio JL
Dis Colon Rectum; 2020 Feb; 63(2):172-182. PubMed ID: 31764246
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival.
Kim RH; Kavanaugh MM; Caldito GC
Surgery; 2017 Jun; 161(6):1633-1641. PubMed ID: 28027818
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive surgery for stage III colon adenocarcinoma is associated with less delay to initiation of adjuvant systemic therapy and improved survival.
Lee L; Wong-Chong N; Kelly JJ; Nassif GJ; Albert MR; Monson JRT
Surg Endosc; 2019 Feb; 33(2):460-470. PubMed ID: 29967992
[TBL] [Abstract][Full Text] [Related]
7. Baseline mortality-adjusted survival in colon cancer patients.
Ukegjini K; Zadnikar M; Warschkow R; Müller S; Schmied BM; Marti L
Langenbecks Arch Surg; 2016 Aug; 401(5):633-41. PubMed ID: 27102323
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic colectomy for colon adenocarcinoma: an 11-year retrospective review with 5-year survival rates.
Jacob BP; Salky B
Surg Endosc; 2005 May; 19(5):643-9. PubMed ID: 15789256
[TBL] [Abstract][Full Text] [Related]
9. Robotic versus laparoscopic colectomy for stage I-III colon cancer: oncologic and long-term survival outcomes.
Mirkin KA; Kulaylat AS; Hollenbeak CS; Messaris E
Surg Endosc; 2018 Jun; 32(6):2894-2901. PubMed ID: 29273877
[TBL] [Abstract][Full Text] [Related]
10. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon.
Read TE; Mutch MG; Chang BW; McNevin MS; Fleshman JW; Birnbaum EH; Fry RD; Caushaj PF; Kodner IJ
J Am Coll Surg; 2002 Jul; 195(1):33-40. PubMed ID: 12113543
[TBL] [Abstract][Full Text] [Related]
11. Trends in lymph node excision and impact of positive lymph node ratio in patients with colectomy for primary colon adenocarcinoma: Population based study 1988 to 2011.
Garcia B; Guzman C; Johnson C; Hellenthal NJ; Monie D; Monzon JR
Surg Oncol; 2016 Sep; 25(3):158-63. PubMed ID: 27566017
[TBL] [Abstract][Full Text] [Related]
12. Predicting Individualized Postoperative Survival for Stage II/III Colon Cancer Using a Mobile Application Derived from the National Cancer Data Base.
Gabriel E; Attwood K; Thirunavukarasu P; Al-Sukhni E; Boland P; Nurkin S
J Am Coll Surg; 2016 Mar; 222(3):232-44. PubMed ID: 26922599
[TBL] [Abstract][Full Text] [Related]
13. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
[TBL] [Abstract][Full Text] [Related]
14. Impact of delay to surgery on survival in stage I-III colon cancer.
Grass F; Behm KT; Duchalais E; Crippa J; Spears GM; Harmsen WS; Hübner M; Mathis KL; Kelley SR; Pemberton JH; Dozois EJ; Larson DW
Eur J Surg Oncol; 2020 Mar; 46(3):455-461. PubMed ID: 31806516
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Delays to Definitive Surgical Care on Survival in Colorectal Cancer Patients.
Trepanier M; Paradis T; Kouyoumdjian A; Dumitra T; Charlebois P; Stein BS; Liberman AS; Schwartzman K; Carli F; Fried GM; Feldman LS; Lee L
J Gastrointest Surg; 2020 Jan; 24(1):115-122. PubMed ID: 31367895
[TBL] [Abstract][Full Text] [Related]
16. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
[TBL] [Abstract][Full Text] [Related]
17. [The long-term follow-up results of the colon cancer treatment].
Pokhorov VV; Nikolaev AV; Vlasov OA; Burlakov MV
Khirurgiia (Mosk); 2011; (3):41-3. PubMed ID: 21423107
[TBL] [Abstract][Full Text] [Related]
18. Five-year survival after curative resection for adenocarcinoma of the colon.
Angelopoulos S; Kanellos I; Christophoridis E; Tsachalis T; Kanellou A; Betsis D
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s152-4. PubMed ID: 15655605
[TBL] [Abstract][Full Text] [Related]
19. The impact of spontaneous tumour perforation on outcome following colon cancer surgery.
Abdelrazeq AS; Scott N; Thorn C; Verbeke CS; Ambrose NS; Botterill ID; Jayne DG
Colorectal Dis; 2008 Oct; 10(8):775-80. PubMed ID: 18266887
[TBL] [Abstract][Full Text] [Related]
20. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study.
Bertelsen CA; Neuenschwander AU; Jansen JE; Wilhelmsen M; Kirkegaard-Klitbo A; Tenma JR; Bols B; Ingeholm P; Rasmussen LA; Jepsen LV; Iversen ER; Kristensen B; Gögenur I;
Lancet Oncol; 2015 Feb; 16(2):161-8. PubMed ID: 25555421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
